Literature DB >> 21768401

Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis.

Yiyi Zhang1, Pamela Ouyang, Wendy S Post, Darshan Dalal, Dhananjay Vaidya, Elena Blasco-Colmenares, Elsayed Z Soliman, Gordon F Tomaselli, Eliseo Guallar.   

Abstract

The association between physiologic levels of sex hormones and QT-interval duration in humans was evaluated using data from 727 men enrolled in the Third National Health and Nutrition Examination Survey and 2,942 men and 1,885 postmenopausal women enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA). Testosterone, estradiol, and sex hormone-binding globulin levels were measured in serum and free testosterone was calculated from those values. QT interval was measured using a standard 12-lead electrocardiogram. In men from the Third National Health and Nutrition Survey, the multivariate adjusted differences in average QT-interval duration comparing the highest quartiles with the lowest quartiles of total testosterone and free testosterone were -8.5 ms (95% confidence interval (CI): -15.5, -1.4) and -8.0 ms (95% CI: -13.2, -2.8), respectively. The corresponding differences were -1.8 ms (95% CI: -3.8, -0.2), and -4.7 ms (95% CI: -6.7, -2.6), respectively, in men from MESA and -0.6 ms (95% CI: -3.0, 1.8) and 0.8 ms (95% CI: -1.6, 3.3), respectively, in postmenopausal women from MESA. Estradiol levels were not associated with QT-interval duration in men, but there was a marginally significant positive association in postmenopausal women. The findings suggest that testosterone levels may explain differences in QT-interval duration between men and women and could be a contributor to population variability in QT-interval duration among men.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768401      PMCID: PMC3202165          DOI: 10.1093/aje/kwr172

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  33 in total

1.  Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women.

Authors:  S Rinaldi; H Déchaud; C Biessy; V Morin-Raverot; P Toniolo; A Zeleniuch-Jacquotte; A Akhmedkhanov; R E Shore; G Secreto; A Ciampi; E Riboli; R Kaaks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-07       Impact factor: 4.254

2.  Nontranscriptional regulation of cardiac repolarization currents by testosterone.

Authors:  Chang-Xi Bai; Junko Kurokawa; Masaji Tamagawa; Haruaki Nakaya; Tetsushi Furukawa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

3.  The effect of estrogen replacement therapy on ventricular repolarization dynamics in healthy postmenopausal women.

Authors:  B Vrtovec; V Starc; H Meden-Vrtovec
Journal:  J Electrocardiol       Date:  2001-10       Impact factor: 1.438

4.  Drug-induced QT prolongation in women during the menstrual cycle.

Authors:  I Rodriguez; M J Kilborn; X K Liu; J C Pezzullo; R L Woosley
Journal:  JAMA       Date:  2001-03-14       Impact factor: 56.272

5.  Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone.

Authors:  H Bidoggia; J P Maciel; N Capalozza; S Mosca; E J Blaksley; E Valverde; G Bertran; P Arini; M O Biagetti; R A Quinteiro
Journal:  Am Heart J       Date:  2000-10       Impact factor: 4.749

6.  Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs.

Authors:  T V Pham; E A Sosunov; R Z Gainullin; P Danilo; M R Rosen
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

7.  The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.

Authors:  Rita Rastogi Kalyani; Manuel Franco; Adrian S Dobs; Pamela Ouyang; Dhananjay Vaidya; Alain Bertoni; Susan M Gapstur; Sherita Hill Golden
Journal:  J Clin Endocrinol Metab       Date:  2009-09-29       Impact factor: 5.958

8.  Effects of estradiol on cardiac ion channel currents.

Authors:  Clemens Möller; Rainer Netzer
Journal:  Eur J Pharmacol       Date:  2006-02-09       Impact factor: 4.432

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  The association of serum testosterone levels and ventricular repolarization.

Authors:  Charlotte van Noord; Marcus Dörr; Miriam C J M Sturkenboom; Sabine M J M Straus; Thorsten Reffelmann; Stephan B Felix; Albert Hofman; Jan A Kors; Robin Haring; Frank H de Jong; Matthias Nauck; André G Uitterlinden; Henri Wallaschofski; Jacqueline C M Witteman; Henry Völzke; Bruno H Ch Stricker
Journal:  Eur J Epidemiol       Date:  2009-12-03       Impact factor: 8.082

View more
  37 in total

Review 1.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

2.  Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 3.  Sex hormones and the QT interval: a review.

Authors:  Tara Sedlak; Chrisandra Shufelt; Carlos Iribarren; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2012-06-04       Impact factor: 2.681

4.  Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking.

Authors:  Lars Anneken; Stefan Baumann; Patrick Vigneault; Peter Biliczki; Corinna Friedrich; Ling Xiao; Zenawit Girmatsion; Ina Takac; Ralf P Brandes; Stefan Kissler; Inka Wiegratz; Sven Zumhagen; Birgit Stallmeyer; Stefan H Hohnloser; Thomas Klingenheben; Eric Schulze-Bahr; Stanley Nattel; Joachim R Ehrlich
Journal:  Eur Heart J       Date:  2015-08-12       Impact factor: 29.983

5.  What causes some patients with drug-induced QT interval prolongation to develop torsades de pointes but not others? The elusive missing link.

Authors:  James E Tisdale
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

Review 6.  QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics.

Authors:  Sanjay Chandrasekhar; Michael G Fradley
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

Review 7.  Role of Testosterone in the Treatment of Cardiovascular Disease.

Authors:  Carolyn M Webb; Peter Collins
Journal:  Eur Cardiol       Date:  2017-12

8.  The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.

Authors:  Pieter-Jan de Kam; Jacqueline van Kuijk; Otilia Lillin; Teun Post; Torben Thomsen
Journal:  Clin Drug Investig       Date:  2014-06       Impact factor: 2.859

9.  Oral contraceptive use and the ECG: evidence of an adverse QT effect on corrected QT interval.

Authors:  Tara Sedlak; Chrisandra Shufelt; Carlos Iribarren; Liisa L Lyon; C Noel Bairey Merz
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05-03       Impact factor: 1.468

Review 10.  Sex differences in cardiac autonomic regulation and in repolarisation electrocardiography.

Authors:  Peter Smetana; Marek Malik
Journal:  Pflugers Arch       Date:  2013-02-13       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.